Biomarker-driven stratification of disease-risk in non-metastatic medulloblastoma: Results from the multi-center HIT-SIOP-PNET4 clinical trial.

Oncotarget · 2015 · PMC4770740 · PMID 26420814

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginally significantno p-value reported

In the non-metastatic patient cohort, R+ disease was independently significant in all analyses, while MB WNT and time to radiotherapy were either significant or marginally significant, consistent with findings from the univariate analysis.

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.